Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 3.25
High: 3.25
Low: 3.25
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

Tue, 02nd Jun 2020 12:57

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Novacyt SA - clinical diagnostics - Says sales of Covid-19 tests totalling EUR135 million at June 1, including EUR45 million already received and forward orders worth an additional EUR90 million. Novacyt says it is selling testing kits to more than 130 countries and wins Zimbabwe contract to supply 1.5 million tests.

----------

Concepta PLC - pregnancy testing and fertility tracking - Reports cost savings made as a result of manufacturing of myLotus fertility tracking product being outsourced. Says in early stages of commercial rollout of myLotus, but announces plans for digital campaign in June.

----------

Hemogenyx Pharmaceuticals PLC - blood disease treatment - Extends development deal with an unnamed global pharmaceutical company due to Covid-19. Partnership to develop CDX antibody candidate extended by three months to complete work.

----------

ValiRx PLC - cancer treatment - To work with Oncolytika Ltd and Black Cat Bio Ltd to explore use of VAL201 in a combination treatment for severe SARS-Cov2 sufferers. ValiRx cautions no guarantee collaboration will result in licensing income.

----------

PureTech Health PLC - biotherapeutics - Says founding entity Gelasis receives approval to market Plenity weight loss treatment in Europe.

----------

Braveheart Investment Group PLC - investment company - Says 80% owned Kirkstall Ltd partnering with Animal Free Research UK, researchers awarding grants to scientists who use techniques to replace use of animals in trials. Says Animal Free Research panel awards outlines projects that will use Kirkstall's Quasi Vivo system in Covid-19 research.

----------

Witan Investment Trust PLC - investor - Says performance so far in 2020 hurt by Covid-19 volatility, with total return at negative 17%, underperforming benchmark which gained 5%. Says UK stocks particularly hit, losing 19% in the period to end of May.

----------

Rambler Metals & Mining PLC - copper and gold producer - Enters into short-term financing agreement with Aether Real Assets Co Investment for GBP1.0 million unsecured loan carrying 10% annual interest, maturing October 5.

----------

Volga Gas PLC - oil and has exploration and production - Says average May production came in an 3,372 barrels of oil equivalent per day, up 45% month-on-month. Adds average price hurt by devaluation of Russian ruble and wider oil price drop.

----------

Ascent Resources PLC - natural resources - Says Slovenian environmental agency has announced Ascent's joint-venture partner Geoenergo doo needs impact assessment before working on PG-10 and PG-11A wells.

----------

Clipper Logistics PLC - logistics - Expects to report full-year earnings before interest, taxes and amortisation of roughly GBP24.0 million, a 19% rise. Reports boosted levels of activity from new and existing customers following initial Covid-19 disruption. Expects EBITA in financial 2021 to beat company-compiled consensus of GBP25.8 million.

----------

Hargreaves Services PLC - industrial and property services - To halt all coal mining operations by July 2020, but will incur GBP3.7 million exceptional cost for year ended May 31, 2020 as a result. Says no material disruption from Covid-19 besides in Property business, where work at a residential site near Edinburgh was suspended.

----------

Quartix Holdings PLC - vehicle tracking - Says trading during the four months to April 30 was stronger year-on-year. Does report however that new fleet installations fell 60% year-on-year in April and 25% annually in May, despite slight rebound as lockdowns eased. Says no material impact on subscription base as a result of Covid-19. Adds pandemic is unlikely to have material impact on profit and cash flow for first half of 2020.

----------

Zotefoams PLC - foam products maker - Maintained operations in April and May, despite challenging demand conditions. Expects trading in the second quarter to be in line with board expectations and forecasts stronger second half.

----------

Water Intelligence PLC - water leak detection - Reacquires San Jose, California franchise to sit within American Leak Detection subsidiary. Allows company to have corporate base in Silicon Valley, offering chance to build on "strong" research and development relationships.

----------

Gusbourne PLC - sparkling wine maker - Says 2020 started strongly but distribution channels hit by Covid-19 since March, though online demand has increased. Winery and vineyards continued production through lockdown, but company has furloughed staff, particularly in sales team. Enters into GBP10.5 million facility with lender PNC Financial Services UK Ltd. Gusbourne says new agreement will refinance existing debts.

----------

Blancco Technology Group PLC - data erasure - Enters in master service agreement to provide Aon Group Co with device diagnostics technology.

----------

Gaming Realms PLC - mobile games - Says licensing revenue continued to grow, surging 80% year-on-year between April and May. Adds revenue helped by new licensing partners like 888casino.com, Sky Betting & Gaming and Draft Kings. Expects earnings before interest, taxes, depreciation and amortisation for 2020 to be significantly ahead of market expectations.

----------

WANdisco PLC - Data and AI - Says it has secured reseller agreement with "large global systems integrator". Reports customer will have access to WANdisco's suite of solutions.

----------

Boku Inc - mobile payments platform - Reports identity services now available in more than 50 countries.

----------

Toople PLC - telecoms - Reports recently-acquired subsidiary Direct Market Services Ltd wins pact to provide IT services to Carluccio's restaurant group.

----------

Iconic Labs PLC - media business - To issue 500.0 million new shares under first tranche of convertible bonds agreement with lender.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
10 Feb 2020 16:00

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
14 Jan 2020 14:50

ValiRx signs letter of intent in a bid to fund VAL401

(Sharecast News) - Clinical-stage biotechnology company ValiRx updated the market on its subsidiary joint venture, ValiSeek, and its cancer therapeutic, VAL401 on Tuesday.

Read more
14 Jan 2020 11:08

ValiRx Joint Venture Partner Enters Agreement For VAL401 Funding

ValiRx Joint Venture Partner Enters Agreement For VAL401 Funding

Read more
6 Jan 2020 09:59

ValiRx Raises GBP200,000 To Progress Product Development

ValiRx Raises GBP200,000 To Progress Product Development

Read more
16 Dec 2019 10:17

ValiRx Reveals "Clear Impact" Of VAL201 On Prostate Cancer Patients

ValiRx Reveals "Clear Impact" Of VAL201 On Prostate Cancer Patients

Read more
28 Nov 2019 16:13

ValiRx granted US patent for 'VAL201' compound

(Sharecast News) - Clinical stage biotechnology company ValiRx announced on Thursday that the US Patent and Trademark Office has granted patent number 10,400,008, titled 'Modulators Of The SRC-Kinase Activity For Preventing Or Treating Metastatic Cancer', to its lead therapeutic compound 'VAL201'.

Read more
28 Nov 2019 15:57

ValiRx Granted "Key" US Patent Protection For VAL201 Cancer Treatment

ValiRx Granted "Key" US Patent Protection For VAL201 Cancer Treatment

Read more
14 Oct 2019 13:44

ValiRx Raises GBP350,000 Through Placing To Progress Clinical Trials

ValiRx Raises GBP350,000 Through Placing To Progress Clinical Trials

Read more
26 Sep 2019 11:43

ValiRx Reports Narrowed Loss In First Half As Expenses Reduce

ValiRx Reports Narrowed Loss In First Half As Expenses Reduce

Read more
24 Sep 2019 12:40

ValiRx Receives GBP423,000 Research & Development Credit From UK HMRC

ValiRx Receives GBP423,000 Research & Development Credit From UK HMRC

Read more
10 Sep 2019 13:45

ValiRx Prostate Cancer Drug VAL201 Still Meeting Endpoints

(Alliance News) - ValiRx PLC on Tuesday said its VAL201 lead compound is still meeting all of its published endpoints and is behaving as expected in prostate cancer.VAL201 has been as a and

Read more
1 Aug 2019 12:01

ValiRx Granted European Patent Allowance For VAL301 Compound

(Alliance News) - Clinical stage biotechnology firm ValiRx PLC said Thursday it has been granted a patent notice of allowance for its pre-clinical therapeutic compound, VAL301, from the European a

Read more
23 Jul 2019 16:25

Monecor Takes Nearly 6% Holding In Biotechnology Firm ValiRx

(Alliance News) - ValiRx PLC on Tuesday said Monecor London Ltd now holds 5.7% interest in the biotechnology company.Prior to this transaction on Monday, Monecor's holding totalled were

Read more
26 Jun 2019 14:30

US Grands Patent Claim For valiRx's VAL201 In Metastatic Cancer

(Alliance News) - ValiRx PLC on Wednesday said the US has allowed a patent claim for the use of VAL201 in metastatic cancer.Shares in ValiRx were down 7.1% at 0.21 pence in afternoon trade

Read more
26 Jun 2019 10:53

ValiRx gets US patent protection for use of VAL201 peptide

(Sharecast News) - Clinical stage biotechnology company ValiRx announced on Wednesday that the US Patent and Trademark Office (USPTO) has allowed patent claims directed towards a method of preventing the worsening of symptoms of metastatic cancer, reducing the progression of metastatic cancer, or treating metastatic cancer - including prostate cancer - by administration of the 'VAL201' peptide.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.